{"id":5493,"date":"2016-04-07T22:21:46","date_gmt":"2016-04-07T22:21:46","guid":{"rendered":"https:\/\/www.olartemoure.com\/web\/en\/om-weekly-digest-07-04-2016\/"},"modified":"2017-04-26T14:31:36","modified_gmt":"2017-04-26T14:31:36","slug":"om-weekly-digest-07-04-2016","status":"publish","type":"post","link":"https:\/\/olartemoure.com\/en\/om-weekly-digest-07-04-2016\/","title":{"rendered":"OM Weekly Digest (07-04-2016)"},"content":{"rendered":"<p><img decoding=\"async\" class=\"aligncenter size-full wp-image-6258\" src=\"https:\/\/www.olartemoure.com\/wp-content\/uploads\/2016\/11\/Cabezote2-eng-01.jpg\" alt=\"\" width=\"800\" height=\"108\" srcset=\"https:\/\/olartemoure.com\/wp-content\/uploads\/2016\/11\/Cabezote2-eng-01.jpg 800w, https:\/\/olartemoure.com\/wp-content\/uploads\/2016\/11\/Cabezote2-eng-01-300x41.jpg 300w, https:\/\/olartemoure.com\/wp-content\/uploads\/2016\/11\/Cabezote2-eng-01-768x104.jpg 768w, https:\/\/olartemoure.com\/wp-content\/uploads\/2016\/11\/Cabezote2-eng-01-461x62.jpg 461w, https:\/\/olartemoure.com\/wp-content\/uploads\/2016\/11\/Cabezote2-eng-01-260x35.jpg 260w, https:\/\/olartemoure.com\/wp-content\/uploads\/2016\/11\/Cabezote2-eng-01-50x7.jpg 50w, https:\/\/olartemoure.com\/wp-content\/uploads\/2016\/11\/Cabezote2-eng-01-150x20.jpg 150w\" sizes=\"(max-width: 800px) 100vw, 800px\" \/><\/p>\n<h3 style=\"text-align: center;\"><span style=\"text-decoration: underline;\"><strong>COLOMBIA\u00a0| Regulatory |\u00a0<strong>First successful registration of company interested in cultivating Cannabis to manufacture and export products for medical purposes<\/strong><\/strong><\/span><\/h3>\n<p><span style=\"color: #ffffff;\">.<\/span><\/p>\n<p style=\"text-align: justify;\">CannaVida S.A.S. is the first company to obtain a registration before the Colombian Narcotics Fund (Fondo Nacional de Estupefacientes \u2013FNE- in Spanish), complying with the first requirement to apply for a crop license, a manufacturing license and an exportation license of Cannabis for medical and scientific purposes. \u00a0According to Decree 2467 (2015), the registration before the FNE (which controls legal access to narcotics) is mandatory in order to apply for the subsequent licenses.<\/p>\n<p>&nbsp;<\/p>\n<h3 style=\"text-align: center;\"><span style=\"text-decoration: underline;\"><strong>COLOMBIA\u00a0| Patents |\u00a0<strong>IP Office grants crystal structure patent<\/strong><\/strong><\/span><\/h3>\n<p><span style=\"color: #ffffff;\">.<\/span><\/p>\n<p style=\"text-align: justify;\">Through <span style=\"text-decoration: underline;\"><a href=\"http:\/\/www.olartemoure.com\/wp-content\/uploads\/2016\/04\/151201-Res.-90232-de-2015-P2014-000117.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Regulation No. 90.232 (2015)<\/a><\/span> the Colombian Patent Office (CPO) recently granted a patent to\u00a0Novartis AG, protecting a crystalline form (polymorph) of an active ingredient useful for treating respiratory diseases (3-(3-{2-[(E)-3,5-Diamino-6-chloro-pyrazine-2-carbonylimino]-1,3,8-triaza-spiro[4.5]decane-8-carbonyl}-benzenesulfonylamino)-propionic acid dipropylcarbamoylmethyl ester succinate).<\/p>\n<p style=\"text-align: justify;\">This case may reflect the most recent and favorable approach of the CPO regarding patent applications reciting polymorphic forms that show unexpected effects and being properly characterized. \u00a0Historically, the CPO&#8217;s standards for granting polymorphs have been subjective such that grants for these solid state forms have varied greatly.<\/p>\n<p>&nbsp;<\/p>\n<h3 style=\"text-align: center;\"><span style=\"text-decoration: underline;\"><strong>PERU | Intellectual Property |\u00a0<strong>Patent Office and Pharmaceutical Laboratories Association identified \u201cadministrative and legal barriers\u201d for the Peruvian pharmaceutical industry<\/strong><\/strong><\/span><\/h3>\n<p><span style=\"color: #ffffff;\">.<\/span><\/p>\n<p style=\"text-align: justify;\">The Academic Observatory of the Peruvian Patent Office (Indecopi) and the Peruvian Pharmaceutical Laboratories Association (Alafarpe) have identified 10 potential administrative and legal barriers that restrict the pharmaceutical industry\u00b4s competitiveness in Peru, with the objective to propose their elimination and improve competitiveness in the market. \u00a0Some of the recommendations are to eliminate delays for the grant of Test Data Protection and the removal of prohibitions related to name changes in products with marketing authorization. The other recommendations <span style=\"text-decoration: underline;\"><a href=\"http:\/\/www.olartemoure.com\/wp-content\/uploads\/2016\/04\/Observatorio-Indecopi-Alafarpe-Resultados-limitaciones-burocr\u00e1ticas-sector-farmac\u00e9utico-Marzo-2016.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">can be viewed here<\/a><\/span>.<\/p>\n<p>&nbsp;<\/p>\n<h3 style=\"text-align: center;\"><span style=\"text-decoration: underline;\"><strong>COLOMBIA\u00a0| Intellectual Property |\u00a0<strong>IP economic rights are now admitted as a guarantee for loans before \u00a0financial institutions<\/strong><\/strong><\/span><\/h3>\n<p><span style=\"color: #ffffff;\">.<\/span><\/p>\n<p style=\"text-align: justify;\"><a href=\"http:\/\/www.olartemoure.com\/wp-content\/uploads\/2016\/04\/Decreto-466-de-2016.pdf\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"text-decoration: underline;\">Decree N\u00b0 466<\/span><\/a> (17 March 2016), which modified Decree 2555 of 2010, includes IP economic rights as a permitted guarantee to support loans before financial institutions.<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>COLOMBIA\u00a0| Regulatory |\u00a0First successful registration of company interested in cultivating Cannabis to manufacture and export products for medical purposes . CannaVida S.A.S. is the first company to obtain a registration before the Colombian Narcotics Fund (Fondo Nacional de Estupefacientes \u2013FNE- in Spanish), complying with the first requirement to apply for a crop license, a manufacturing [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":6260,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[],"tags":[],"class_list":["post-5493","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.4 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>OM Weekly Digest (07-04-2016) - OlarteMoure | Intellectual Property<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/olartemoure.com\/en\/om-weekly-digest-07-04-2016\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"OM Weekly Digest (07-04-2016)\" \/>\n<meta property=\"og:description\" content=\"COLOMBIA\u00a0| Regulatory |\u00a0First successful registration of company interested in cultivating Cannabis to manufacture and export products for medical purposes . CannaVida S.A.S. is the first company to obtain a registration before the Colombian Narcotics Fund (Fondo Nacional de Estupefacientes \u2013FNE- in Spanish), complying with the first requirement to apply for a crop license, a manufacturing [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/olartemoure.com\/en\/om-weekly-digest-07-04-2016\/\" \/>\n<meta property=\"og:site_name\" content=\"OlarteMoure | Intellectual Property\" \/>\n<meta property=\"article:published_time\" content=\"2016-04-07T22:21:46+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2017-04-26T14:31:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/olartemoure.com\/wp-content\/uploads\/2016\/11\/Imagen-eng-03.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"842\" \/>\n\t<meta property=\"og:image:height\" content=\"482\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/om-weekly-digest-07-04-2016\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/om-weekly-digest-07-04-2016\\\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/olartemoure.com\\\/#\\\/schema\\\/person\\\/d3c1a99aa6e1d8fc8bb6a5c4dee16807\"},\"headline\":\"OM Weekly Digest (07-04-2016)\",\"datePublished\":\"2016-04-07T22:21:46+00:00\",\"dateModified\":\"2017-04-26T14:31:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/om-weekly-digest-07-04-2016\\\/\"},\"wordCount\":343,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/om-weekly-digest-07-04-2016\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/olartemoure.com\\\/wp-content\\\/uploads\\\/2016\\\/11\\\/Imagen-eng-03.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/om-weekly-digest-07-04-2016\\\/\",\"url\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/om-weekly-digest-07-04-2016\\\/\",\"name\":\"OM Weekly Digest (07-04-2016) - OlarteMoure | Intellectual Property\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/olartemoure.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/om-weekly-digest-07-04-2016\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/om-weekly-digest-07-04-2016\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/olartemoure.com\\\/wp-content\\\/uploads\\\/2016\\\/11\\\/Imagen-eng-03.jpg\",\"datePublished\":\"2016-04-07T22:21:46+00:00\",\"dateModified\":\"2017-04-26T14:31:36+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/olartemoure.com\\\/#\\\/schema\\\/person\\\/d3c1a99aa6e1d8fc8bb6a5c4dee16807\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/om-weekly-digest-07-04-2016\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/olartemoure.com\\\/en\\\/om-weekly-digest-07-04-2016\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/om-weekly-digest-07-04-2016\\\/#primaryimage\",\"url\":\"https:\\\/\\\/olartemoure.com\\\/wp-content\\\/uploads\\\/2016\\\/11\\\/Imagen-eng-03.jpg\",\"contentUrl\":\"https:\\\/\\\/olartemoure.com\\\/wp-content\\\/uploads\\\/2016\\\/11\\\/Imagen-eng-03.jpg\",\"width\":\"842\",\"height\":\"482\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/om-weekly-digest-07-04-2016\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"OM Weekly Digest (07-04-2016)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/olartemoure.com\\\/#website\",\"url\":\"https:\\\/\\\/olartemoure.com\\\/\",\"name\":\"OlarteMoure | Intellectual Property\",\"description\":\"Firma especializada en Propiedad Intelectual\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/olartemoure.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/olartemoure.com\\\/#\\\/schema\\\/person\\\/d3c1a99aa6e1d8fc8bb6a5c4dee16807\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/dc39656c8e7d8a5a4ca66eb97abd4b095991d687cfd38af1e37bac8f9cb122b7?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/dc39656c8e7d8a5a4ca66eb97abd4b095991d687cfd38af1e37bac8f9cb122b7?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/dc39656c8e7d8a5a4ca66eb97abd4b095991d687cfd38af1e37bac8f9cb122b7?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"url\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/author\\\/admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"OM Weekly Digest (07-04-2016) - OlarteMoure | Intellectual Property","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/olartemoure.com\/en\/om-weekly-digest-07-04-2016\/","og_locale":"en_US","og_type":"article","og_title":"OM Weekly Digest (07-04-2016)","og_description":"COLOMBIA\u00a0| Regulatory |\u00a0First successful registration of company interested in cultivating Cannabis to manufacture and export products for medical purposes . CannaVida S.A.S. is the first company to obtain a registration before the Colombian Narcotics Fund (Fondo Nacional de Estupefacientes \u2013FNE- in Spanish), complying with the first requirement to apply for a crop license, a manufacturing [&hellip;]","og_url":"https:\/\/olartemoure.com\/en\/om-weekly-digest-07-04-2016\/","og_site_name":"OlarteMoure | Intellectual Property","article_published_time":"2016-04-07T22:21:46+00:00","article_modified_time":"2017-04-26T14:31:36+00:00","og_image":[{"width":842,"height":482,"url":"https:\/\/olartemoure.com\/wp-content\/uploads\/2016\/11\/Imagen-eng-03.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/olartemoure.com\/en\/om-weekly-digest-07-04-2016\/#article","isPartOf":{"@id":"https:\/\/olartemoure.com\/en\/om-weekly-digest-07-04-2016\/"},"author":{"name":"admin","@id":"https:\/\/olartemoure.com\/#\/schema\/person\/d3c1a99aa6e1d8fc8bb6a5c4dee16807"},"headline":"OM Weekly Digest (07-04-2016)","datePublished":"2016-04-07T22:21:46+00:00","dateModified":"2017-04-26T14:31:36+00:00","mainEntityOfPage":{"@id":"https:\/\/olartemoure.com\/en\/om-weekly-digest-07-04-2016\/"},"wordCount":343,"commentCount":0,"image":{"@id":"https:\/\/olartemoure.com\/en\/om-weekly-digest-07-04-2016\/#primaryimage"},"thumbnailUrl":"https:\/\/olartemoure.com\/wp-content\/uploads\/2016\/11\/Imagen-eng-03.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/olartemoure.com\/en\/om-weekly-digest-07-04-2016\/","url":"https:\/\/olartemoure.com\/en\/om-weekly-digest-07-04-2016\/","name":"OM Weekly Digest (07-04-2016) - OlarteMoure | Intellectual Property","isPartOf":{"@id":"https:\/\/olartemoure.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/olartemoure.com\/en\/om-weekly-digest-07-04-2016\/#primaryimage"},"image":{"@id":"https:\/\/olartemoure.com\/en\/om-weekly-digest-07-04-2016\/#primaryimage"},"thumbnailUrl":"https:\/\/olartemoure.com\/wp-content\/uploads\/2016\/11\/Imagen-eng-03.jpg","datePublished":"2016-04-07T22:21:46+00:00","dateModified":"2017-04-26T14:31:36+00:00","author":{"@id":"https:\/\/olartemoure.com\/#\/schema\/person\/d3c1a99aa6e1d8fc8bb6a5c4dee16807"},"breadcrumb":{"@id":"https:\/\/olartemoure.com\/en\/om-weekly-digest-07-04-2016\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/olartemoure.com\/en\/om-weekly-digest-07-04-2016\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/olartemoure.com\/en\/om-weekly-digest-07-04-2016\/#primaryimage","url":"https:\/\/olartemoure.com\/wp-content\/uploads\/2016\/11\/Imagen-eng-03.jpg","contentUrl":"https:\/\/olartemoure.com\/wp-content\/uploads\/2016\/11\/Imagen-eng-03.jpg","width":"842","height":"482"},{"@type":"BreadcrumbList","@id":"https:\/\/olartemoure.com\/en\/om-weekly-digest-07-04-2016\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/olartemoure.com\/en\/"},{"@type":"ListItem","position":2,"name":"OM Weekly Digest (07-04-2016)"}]},{"@type":"WebSite","@id":"https:\/\/olartemoure.com\/#website","url":"https:\/\/olartemoure.com\/","name":"OlarteMoure | Intellectual Property","description":"Firma especializada en Propiedad Intelectual","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/olartemoure.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/olartemoure.com\/#\/schema\/person\/d3c1a99aa6e1d8fc8bb6a5c4dee16807","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/dc39656c8e7d8a5a4ca66eb97abd4b095991d687cfd38af1e37bac8f9cb122b7?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/dc39656c8e7d8a5a4ca66eb97abd4b095991d687cfd38af1e37bac8f9cb122b7?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/dc39656c8e7d8a5a4ca66eb97abd4b095991d687cfd38af1e37bac8f9cb122b7?s=96&d=mm&r=g","caption":"admin"},"url":"https:\/\/olartemoure.com\/en\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/posts\/5493","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/comments?post=5493"}],"version-history":[{"count":0,"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/posts\/5493\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/media\/6260"}],"wp:attachment":[{"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/media?parent=5493"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/categories?post=5493"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/tags?post=5493"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}